Axim Biotech announces first-ever successful achievement of proprietary cGMP extraction and manufacturing methods for pure cannabinoid molecules. Axim Biotechnologies, a major investment company in Medical Marijuana, Inc., has successfully executed its first-ever proprietary current good manufacturing practices (cGMP) methodology in the extraction and microencapsulation of cannabinoid molecules for a variety of pharmaceutical delivery formats from cGMP-produced medicinal…